Pleural effusion risk factors: Difference between revisions
Jump to navigation
Jump to search
Prince Djan (talk | contribs) |
Prince Djan (talk | contribs) |
||
| Line 12: | Line 12: | ||
*Pre-existing lung damage or disease. | *Pre-existing lung damage or disease. | ||
*Chronic smokers. | *Chronic smokers. | ||
*neoplasia example lung cancer patients and individuals with any other type of lung tumor<ref name="pmid20440084">{{cite journal| author=Zablockis R, Petruskeviciene R, Nargela RV| title=[Causes and risk factors of pleural empyema and complicated parapneumonic pleural effusion]. | journal=Medicina (Kaunas) | year= 2010 | volume= 46 | issue= 2 | pages= 113-9 | pmid=20440084 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20440084 }} </ref> | |||
*alcohol abuse<ref name="pmid20440084">{{cite journal| author=Zablockis R, Petruskeviciene R, Nargela RV| title=[Causes and risk factors of pleural empyema and complicated parapneumonic pleural effusion]. | journal=Medicina (Kaunas) | year= 2010 | volume= 46 | issue= 2 | pages= 113-9 | pmid=20440084 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20440084 }} </ref> | |||
*Liver cirrhosis. | *Liver cirrhosis. | ||
*Use of certain medications example dasatinib in the treatment of patients with chronic myelogenous leukaemia.<ref name="pmid22815278">{{cite journal| author=Latagliata R, Breccia M, Fava C, Stagno F, Tiribelli M, Luciano L et al.| title=Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia. | journal=Hematol Oncol | year= 2013 | volume= 31 | issue= 2 | pages= 103-9 | pmid=22815278 | doi=10.1002/hon.2020 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22815278 }} </ref> | *Use of certain medications example dasatinib in the treatment of patients with chronic myelogenous leukaemia.<ref name="pmid22815278">{{cite journal| author=Latagliata R, Breccia M, Fava C, Stagno F, Tiribelli M, Luciano L et al.| title=Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia. | journal=Hematol Oncol | year= 2013 | volume= 31 | issue= 2 | pages= 103-9 | pmid=22815278 | doi=10.1002/hon.2020 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22815278 }} </ref>and immunosuppressive medicine<ref name="pmid20440084">{{cite journal| author=Zablockis R, Petruskeviciene R, Nargela RV| title=[Causes and risk factors of pleural empyema and complicated parapneumonic pleural effusion]. | journal=Medicina (Kaunas) | year= 2010 | volume= 46 | issue= 2 | pages= 113-9 | pmid=20440084 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20440084 }} </ref> | ||
*Occupational exposure to asbestos. | *Occupational exposure to asbestos. | ||
*Heart failure. | *Heart failure. | ||
*As a complication of some surgical procedures example Nuss procedure for correction of pectus excavatum.<ref name="pmid23411850">{{cite journal| author=Cheng YL, Lin CT, Wang HB, Chang H| title=Pleural effusion complicating after Nuss procedure for pectus excavatum. | journal=Ann Thorac Cardiovasc Surg | year= 2014 | volume= 20 | issue= 1 | pages= 6-11 | pmid=23411850 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23411850 }} </ref> | *As a complication of some surgical procedures example Nuss procedure for correction of pectus excavatum.<ref name="pmid23411850">{{cite journal| author=Cheng YL, Lin CT, Wang HB, Chang H| title=Pleural effusion complicating after Nuss procedure for pectus excavatum. | journal=Ann Thorac Cardiovasc Surg | year= 2014 | volume= 20 | issue= 1 | pages= 6-11 | pmid=23411850 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23411850 }} </ref> | ||
Surgery-related risk factors include the following:<ref name="pmid15173721">{{cite journal| author=Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V| title=Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. | journal=J Thorac Cardiovasc Surg | year= 2004 | volume= 127 | issue= 6 | pages= 1664-9 | pmid=15173721 | doi=10.1016/j.jtcvs.2003.09.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15173721 }} </ref> | Surgery-related risk factors include the following:<ref name="pmid15173721">{{cite journal| author=Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V| title=Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. | journal=J Thorac Cardiovasc Surg | year= 2004 | volume= 127 | issue= 6 | pages= 1664-9 | pmid=15173721 | doi=10.1016/j.jtcvs.2003.09.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15173721 }} </ref> | ||
Revision as of 16:45, 18 October 2016
|
Pleural effusion Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleural effusion risk factors On the Web |
|
American Roentgen Ray Society Images of Pleural effusion risk factors |
|
Risk calculators and risk factors for Pleural effusion risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
Risk Factors
Common risk factors in the development of pleural effusion are as follows:
- Increased serum VEGF, TNF-α and C3 levels are identified as important risk factors for presence of pleural effusions in POEMS syndrome.[1]
- Pre-existing lung damage or disease.
- Chronic smokers.
- neoplasia example lung cancer patients and individuals with any other type of lung tumor[2]
- alcohol abuse[2]
- Liver cirrhosis.
- Use of certain medications example dasatinib in the treatment of patients with chronic myelogenous leukaemia.[3]and immunosuppressive medicine[2]
- Occupational exposure to asbestos.
- Heart failure.
- As a complication of some surgical procedures example Nuss procedure for correction of pectus excavatum.[4]
Surgery-related risk factors include the following:[5]
- Lower preoperative oxygen saturation
- presence of postoperative infection
- smaller conduit size
- longer duration of cardiopulmonary bypass
References
- ↑ Cui RT, Yu SY, Huang XS, Zhang JT, Tian CL, Dou LP; et al. (2015). "Incidence and risk factors of pleural effusions in patients with POEMS syndrome". Hematol Oncol. 33 (2): 80–4. doi:10.1002/hon.2135. PMID 24519469.
- ↑ 2.0 2.1 2.2 Zablockis R, Petruskeviciene R, Nargela RV (2010). "[Causes and risk factors of pleural empyema and complicated parapneumonic pleural effusion]". Medicina (Kaunas). 46 (2): 113–9. PMID 20440084.
- ↑ Latagliata R, Breccia M, Fava C, Stagno F, Tiribelli M, Luciano L; et al. (2013). "Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia". Hematol Oncol. 31 (2): 103–9. doi:10.1002/hon.2020. PMID 22815278.
- ↑ Cheng YL, Lin CT, Wang HB, Chang H (2014). "Pleural effusion complicating after Nuss procedure for pectus excavatum". Ann Thorac Cardiovasc Surg. 20 (1): 6–11. PMID 23411850.
- ↑ Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V (2004). "Risk factors for persistent pleural effusions after the extracardiac Fontan procedure". J Thorac Cardiovasc Surg. 127 (6): 1664–9. doi:10.1016/j.jtcvs.2003.09.011. PMID 15173721.